US Broker Ratings

AMN Healthcare Services Inc (AMN): Investor Outlook Amidst Challenging Valuation and Growth Metrics

AMN Healthcare Services Inc (NYSE: AMN) navigates a complex landscape in the healthcare sector, offering a variety of technology-enabled workforce solutions and staffing services essential for..

GH Research PLC (GHRS) Investor Outlook: Biotech Stock Poised for 147.96% Upside Potential

GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company based in Dublin, Ireland, is making waves in the biotechnology sector with its focus on innovative treatments..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Unraveling a Potential 234.60% Upside in the Biotech Arena

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is capturing investor attention with a notable potential upside of 234.60%, as the company positions itself on the cutting edge..

Nuvation Bio Inc. (NUVB) Stock Analysis: Biotechnology Innovator with 58.58% Potential Upside

Nuvation Bio Inc. (NUVB), a clinical-stage biopharmaceutical company based in New York, is capturing investor attention with its promising oncology pipeline and significant potential upside. Trading..

uniQure N.V. (QURE) Stock Analysis: A Closer Look at Its 9.79% Potential Upside and Robust Pipeline

Investors eyeing the biotechnology sector may find uniQure N.V. (QURE), a leading player in the gene therapy space, an intriguing opportunity. With a market capitalization of..

STAAR Surgical Company (STAA) Stock Analysis: Navigating the Healthcare Sector with a 186.83 Forward P/E

STAAR Surgical Company (NASDAQ: STAA) stands as a noteworthy entity in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Delcath Systems, Inc. (DCTH) Stock Analysis: Major Upside Potential with a 150% Target Price Surge

For investors keen on tapping into the healthcare sector, Delcath Systems, Inc. (NASDAQ: DCTH) presents an intriguing opportunity. With a focus on innovative treatments for liver..

Immunome, Inc. (IMNM) Stock Analysis: Unpacking a 50% Potential Upside in Biotech

Immunome, Inc. (NASDAQ: IMNM) is capturing the attention of investors in the healthcare sector with its promising biotech developments and the potential for significant stock appreciation...

CeriBell, Inc. (CBLL) Stock Analysis: A 151% Potential Upside in the Healthcare Sector

CeriBell, Inc. (CBLL), a promising player in the healthcare sector, is capturing investor attention with its innovative approach to neurological care. The company, headquartered in Sunnyvale,..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A High-Stakes Biotech with 43% Upside Potential

Praxis Precision Medicines, Inc. (PRAX) is gaining attention in the biotechnology sector, particularly among investors with a keen interest in companies developing breakthrough therapies for central..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Navigating the Biotech Waters with a 48.8% Revenue Boost

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) has been making waves in the biotechnology industry with its innovative approach to addressing chronic endocrine and neurological diseases. Headquartered..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a 20.5% Revenue Growth Amidst Market Challenges

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid sector, is capturing investor attention with its noteworthy 20.5% revenue growth, despite facing a complex..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: A Potential 56.69% Upside in the Biotech Arena

Arcus Biosciences, Inc. (NASDAQ: RCUS) is making waves in the biotechnology sector with its promising portfolio of cancer therapies. As a clinical-stage biopharmaceutical company, Arcus is..

Syndax Pharmaceuticals, Inc. (SNDX) Investor Outlook: A Potential 186% Upside on Promising Cancer Therapies

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) stands out in the biotechnology sector with a compelling growth narrative, particularly for investors seeking exposure to innovative cancer treatments. With..

Zymeworks Inc. (ZYME) Stock Analysis: Biotechnology Innovator with a 27.9% Potential Upside

Zymeworks Inc. (NASDAQ: ZYME), a burgeoning player in the biotechnology sector, has caught the attention of investors with its promising therapeutic platforms and partnerships. With a..

CareDx, Inc. (CDNA) Stock Analysis: Uncovering a Potential 50.89% Upside in the Diagnostics Sector

As the healthcare landscape continues to evolve, CareDx, Inc. (NASDAQ: CDNA) stands out within the diagnostics and research industry. With a market capitalization of $770.19 million,..

InMode Ltd. (INMD) Stock Analysis: Exploring the 13% Potential Upside in Medical Device Innovator

In the rapidly evolving healthcare sector, InMode Ltd. (NASDAQ: INMD) stands out as a noteworthy player in the medical devices industry. Headquartered in Yokne’am, Israel, InMode..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Unveiling a Potential 135% Upside in the Biotech Sector

Gyre Therapeutics, Inc. (NASDAQ: GYRE), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to developing small-molecule drugs..

Ardelyx, Inc. (ARDX) Stock Analysis: A 126% Potential Upside for Biotech Enthusiasts

Ardelyx, Inc. (NASDAQ: ARDX) is garnering attention in the biotechnology sector, with a notable potential upside of 126.82% based on current analyst ratings. This Waltham, Massachusetts-based..

CureVac N.V. (CVAC) Stock Analysis: Riding the mRNA Wave Amidst Challenges

Investors eyeing the biotechnology sector are increasingly focusing on CureVac N.V. (NASDAQ: CVAC), a German biopharmaceutical company with a market cap of $1.21 billion. Known for..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds